Clarity Pharmaceuticals (ASX:CU6) Enhances Breast Cancer Pipeline with Cu-SAR-trastuzumab
Clarity Pharmaceuticals (ASX:CU6) enhances its breast cancer pipeline with new radiopharmaceutical and secures critical supply agreement.
Clarity Pharmaceuticals (ASX:CU6) enhances its breast cancer pipeline with new radiopharmaceutical and secures critical supply agreement.
Kinetiko Energy (ASX:KKO) reports successful gas production tests, maintaining a 100% gas encounter rate and initiating an optimization study.
EV Resources (ASX:EVR) advances its Parag project to supply molybdenum to the USA amidst China’s export controls.
Matsa Resources Limited (ASX:MAT) reports a new high-grade gold intercept at Fortitude North, enhancing their exploration model and future drilling plans.
National Australia Bank extends loan maturity and defers interest payments for Cann Group (ASX:CAN), enhancing financial flexibility.
Amaero International Limited (ASX:3DA) raises A$22 million through institutional placement, securing funding for FY2026 commercialisation.
Altair Minerals (ASX:ALR) discovers a new Central Porphyry system at Venatica, boosting copper exploration potential.
Solis Minerals (ASX:SLM) confirms significant copper mineralisation at its Cinto Project in Peru, highlighting expansion and future drilling plans.
Challenger Gold Limited (ASX:CEL) reports excellent progress on Toll Milling readiness, with increased ore grades and a robust mining schedule.
Askari Metals (ASX:AS2) upgrades Burracoppin Gold Project’s resource by 28%, attracting significant investor interest.